&w=3840&q=100)
Cummins India shares rise on launching battery energy storage systems
The diesel and natural gas engines maker's stock rose as much as 2.1 per cent during the day to ₹3,388.6 per share. The stock pared gains to trade 1.8 per cent higher at ₹3,389 apiece, compared to a 0.52 per cent advance in Nifty 50 as of 12:50 PM.
Shares of the company have gained for the third straight session. The counter has risen 3.3 per cent this year, compared to a 7 per cent advance in the benchmark Nifty 50. Cummins India has a total market capitalisation of ₹93,811.41 crore, according to BSE data. Track LIVE Stock Market Updates Here
Cummins India Launches BESS
The company launched its battery energy storage systems, expanding its sustainable solutions portfolio under the company's 'Destination Zero' strategy, according to an exchange filing on Thursday. "This system is designed to support India's clean energy transition and strengthen the reliability of the country's power infrastructure," it said.
BESS technology enables integration of renewable and intermittent energy sources like solar and wind with existing infrastructure, providing benefits such as peak shaving, energy shifting, and optimised energy costs. It is expected to find strong demand across industries such as manufacturing, data centres, real estate, and mining, the company said in the statement.
India's energy landscape is undergoing a major shift, driven by climate goals and growing renewable adoption, Shveta Arya, managing director of Cummins India, said. 'Our BESS offers a reliable, scalable, and sustainable foundation for the energy ecosystem of tomorrow,' she said, adding that the solution aligns with India's net-zero ambitions for 2070 and underscores Cummins' commitment to purposeful innovation.
Cummins India Q4 result 2025
In the quarter ended March 31, 2025, the company posted a consolidated net profit of ₹529.5 crore as against ₹538.86 crore a year ago, down 2 per cent. Its revenue from operations stood at ₹2,470.38 crore as compared to ₹2,319.02 crore a year ago, up 6.5 per cent.
About Cummins India
Cummins India is a power solutions provider in the country. It is involved in the power generation, aftermarket, and export businesses. The company has a strong manufacturing backbone and has five manufacturing plants, assembly, and distribution facilities. With over 480 customer touchpoints, the company is committed to powering the success of its customers and ensuring that its services and solutions are readily accessible.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
an hour ago
- The Print
Sensex, Nifty decline on concerns over US tariff imposition
Halting its two-day rally, the 30-share BSE index declined 296.28 points, or 0.36 per cent, to settle at 81,185.58 after recovering some lost ground during the afternoon trade. During the morning session, the gauge tanked 786.71 points, or 0.96 per cent, to 80,695.15. Despite the weak start, the indices staged a sharp recovery, but selling pressure re-emerged towards the fag of the session. However, buying in some heavyweight stocks restricted the downward trend, traders said. Mumbai, Jul 31 (PTI) Equity benchmark indices Sensex and Nifty ended lower on Thursday after US President Donald Trump announced the imposition of a 25 per cent tariff on all goods coming from India starting August 1 and an unspecified penalty for buying Russian crude oil and military equipment. As many as 2,418 stocks declined, while 1,598 advanced and 137 remained unchanged on the BSE. The 50-share NSE Nifty dropped 86.70 points or 0.35 per cent to 24,768.35. 'Following a turbulent start driven by fresh tariff threats, the Indian market started on a pessimistic note. However, the domestic market attempted a strong recovery, but by the end of the day, it closed with marginal losses on a monthly expiry day. 'Investors gravitated toward domestically oriented, non-discretionary players, especially FMCG, which offered attractive valuations, demand outlook and relative insulation from tariff risks. In contrast, oil & gas stocks were the worst hit due to US warnings over Indian energy imports,' Vinod Nair, Head of Research, Geojit Investments Limited, said. The announcement is being seen as a pressure tactic to get New Delhi to agree to demands made by the US, which has, in recent days, got favourable trade deals with major partners like Japan, the UK and the European Union. The penalty was announced as India has made large purchases of oil and military equipment from Russia. India is the first country to face a penalty for Russian imports. From the Sensex firms, Tata Steel, Sun Pharma, Reliance Industries, Adani Ports, NTPC and Asian Paints were among the biggest laggards. However, FMCG major Hindustan Unilever Ltd (HUL) jumped 3.48 per cent after the firm reported a 5.97 per cent rise in its consolidated net profit to Rs 2,768 crore for the June quarter of FY26, helped by gains from a re-estimation of taxes paid in the previous year. Eternal, ITC, Kotak Mahindra Bank and Power Grid were also among the gainers. 'Markets witnessed volatile swings on the monthly expiry day and ended marginally lower amid mixed cues. The surprise tariff announcement by the US President on India initially triggered a knee-jerk reaction; however, a gradual recovery in heavyweight stocks across sectors helped the index briefly turn positive. Selling pressure resurfaced in the final hours, once again putting bulls on the back foot. As a result, the Nifty closed at 24,768.35, down 0.35 per cent,' Ajit Mishra – SVP, Research, Religare Broking Ltd, said. The BSE smallcap gauge dropped 0.85 per cent and the midcap index dipped 0.70 per cent. Among BSE sectoral indices, telecommunication tanked 1.80 per cent, oil & gas (1.47 per cent), energy (1.40 per cent), metal (1.18 per cent), commodities (1.03 per cent), and consumer durables (0.78 per cent). FMCG and services were the gainers. In Asian markets, South Korea's Kospi, Shanghai's SSE Composite index and Hong Kong's Hang Seng settled lower, while Japan's Nikkei 225 index ended in positive territory. European markets were trading on a mixed note in mid-session trade. The US markets ended mostly lower on Wednesday. Global oil benchmark Brent crude dipped 0.74 per cent to USD 72.70 per barrel. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 850.04 crore on Wednesday, according to exchange data. In the previous session, the Sensex climbed 143.91 points or 0.18 per cent to settle at 81,481.86. The Nifty rose 33.95 points or 0.14 per cent to 24,855.05. PTI SUM SUM BAL BAL This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Sun Pharma Q1 net profit falls 20% Y-o-Y; revenue rises 9%
Litigation, drug discontinuation weigh on earnings; US market remains sluggish even as India sales and Leqselvi launch boost specialty push Sun Pharmaceutical, India's largest drugmaker, has posted a decline of 20 per cent year-on-year (Y-o-Y) in its consolidated net profit for the first quarter of 2025-26 (Q1FY26). While its net profit was ₹2,278 crore, its revenue from operations rose 9 per cent at ₹13,851 crore. The fall in profit is primarily because of discontinuing the development of SCD-044, an investigational drug (₹287.6 crore), and a litigation settlement involving Taro and SPIINC (₹530.3 crore). This was despite an exceptional tax credit of ₹100.5 crore. Sequentially net profit rose 6 per cent with revenue rising 7 per cent. The muted performance in the United States (US), the company's largest overseas market, is a key concern, with formulation sales there up only 1.5 per cent Y-o-Y at $473 million, contributing 29 per cent to consolidated revenues. 'The US launch of Leqselvi represents an important step forward, offering a new treatment option for patients with severe alopecia areata,' said Chairman and Managing Director Dilip Shanghvi. He added that Leqselvi strengthened Sun's dermatology franchise and was expected to be a growth driver. The results came during market hours. Sun's stock fell 1.6 per cent, ending the day's trade at ₹1,705.5 on the BSE. Shanghvi said: 'The launch of Leqselvi represents an important step forward, offering a new treatment option for patients with severe alopecia areata. Leqselvi augments our portfolio in dermatology and adds a growth engine to our innovative medicines business.' Formulation sales in India stood at ₹4,721 crore, up 14 per cent Y-o-Y, contributing 34 per cent to consolidated sales for the quarter. Sun Pharma retained its number 1 ranking in the Indian pharmaceutical market, with market share rising from 8 per cent to 8.3 per cent, according to Pharmarack MAT June 2025 data. The company launched five products during April-June.
Time of India
an hour ago
- Time of India
P&G Hygiene and Health Jun qtr profit up twofold to Rs 192 cr, revenue at Rs 937 cr
New Delhi: Procter & Gamble Hygiene and Health Care Ltd on Wednesday reported an over two-fold jump in its profit after tax to Rs 192.06 crore in the quarter ended June 2025. The company had reported a profit after tax of Rs 81.06 crore in the corresponding quarter of the previous fiscal. Revenue from operations of Procter & Gamble Hygiene and Health Care Ltd (PGHH) was marginally up by 0.56 per cent to Rs 937.03 crore in the June quarter. The same stood at Rs 931.75 crore in the corresponding period a year ago. The company's PAT was "significantly up due to the impact of higher advertising investment in the base period," according to the earnings statement from PGHH, which operates in the healthcare and feminine care segment with brands Vicks and Whisper in its portfolio. PGHH's total expenses declined 17.75 per cent to Rs 680.02 crore in the June quarter. Its total income, which includes other income, grew marginally to Rs 944.72 crore during the quarter on a year-on-year basis. In January this year, PGHH's board had approved a change of financial year of the company from July-June to April-March. "Accordingly, the previous financial year of the company viz, 2024-25 was for a period of nine months commencing on July 1, 2024, and ended on March 31, 2025," it said. Shares of Procter & Gamble Hygiene and Health Care Ltd settled at Rs 13,885 apiece on the BSE, up 6.12 per cent from the previous close. PTI
